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ABSTRACT: Upon infecting a red blood cell (RBC), the malaria
parasite Plasmodium falciparum drastically remodels its host by
exporting hundreds of proteins into the RBC cytosol. This protein
export program is essential for parasite survival. Hence export-related
proteins could be potential drug targets. One essential enzyme in this
pathway is plasmepsin V (PMV), an aspartic protease that processes
export-destined proteins in the parasite endoplasmic reticulum (ER)
at the Plasmodium export element (PEXEL) motif. Despite longstanding interest in this enzyme, functional studies have been
hindered by the inability of previous technologies to produce a
regulatable lethal depletion of PMV. To overcome this technical
barrier, we designed a system for stringent post-transcriptional
regulation allowing a tightly controlled, tunable knockdown of PMV.
Using this system, we found that PMV must be dramatically depleted
to aﬀect parasite growth, suggesting the parasite maintains this enzyme in substantial excess. Surprisingly, depletion of PMV arrested
parasite growth immediately after RBC invasion, signiﬁcantly before the death from exported protein deﬁcit that has previously been
described. The data suggest that PMV inhibitors can halt parasite growth at two distinct points in the parasite life cycle. However,
overcoming the functional excess of PMV in the parasite may require inhibitor concentrations far beyond the enzyme’s IC50.
KEYWORDS: aspartic protease, malaria, CRISPR/Cas9, knockdown, protein export, dense granule
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variant signal recognition particle complex.7 Cleavage occurs at
the conserved amino acid motif RxLxE/Q/D, termed the
Plasmodium export element (PEXEL).8−12 PMV is highly
speciﬁc for RxL in the PEXEL and cleaves after the
leucine.10,13,14 PEXEL processing is a critical step in protein
export, as mutations in PEXEL that block PMV processing also
block protein export.11,12 Furthermore, processing of PEXEL
proteins is likely an essential function in the parasite, as PMV is
essential for survival in both P. falciparum and the related
rodent parasite P. berghei, and treatment with a PEXEL
peptidomimetic is lethal to intraerythrocytic parasites.6,15−17
A number of tools have been used to study PMV, including
peptidomimetic inhibitors that block its function in vitro and
are lethal to parasites in culture, a DiCre-mediated inducible
excision of the gene, and crystallographic studies of P. vivax
PMV.6,16−18 However, study of PMV function has been
hindered by an inability of previous depletions to yield a

alaria remains a scourge of the developing world,
causing nearly 500 000 deaths per year, with the
overwhelming majority due to Plasmodium falciparum
infection.1 While the life cycle of P. falciparum includes
replication in both the liver and blood, symptomatic human
disease is caused by infection of red blood cells (RBCs).2
Upon infection of a host RBC, the parasite executes a dramatic
program of protein export, sending hundreds of proteins
through the secretory system, across the surrounding vacuole
(parasitophorous vacuole, PV) through a parasite-encoded
translocation complex, and into the host cytosol.3,4 These
exported eﬀectors drastically remodel the host cell, setting up
new solute permeability pathways, modifying the RBC shape
and rigidity, and reconstituting traﬃcking machinery in the
RBC cytosol to send parasite-encoded adhesins to the RBC
surface.3,4 These adhesins mediate binding of infected RBCs to
vascular endothelia allowing parasites to avoid splenic
clearance. Adherent parasites in the brain can cause vascular
leakage leading to death in severe cases.2
Due to the central role of protein export in the survival and
virulence of P. falciparum, there has been interest in this
pathway as a source of potential drug targets.5 One essential
enzyme in the pathway is the parasite aspartic protease
plasmepsin V (PMV).6,8,9 PMV processes exported proteins in
the parasite ER13 by cleaving them cotranslationally in a
© 2020 American Chemical Society
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Figure 1. Architecture of pSN054 and application to editing PMV. (A) Schematic of pSN054 showing restriction sites (dashed lines), loxP (red
triangles), aptamers (black lollipops), and 2A skip peptide (pink rectangle). Restriction sites allow the choice of 3x-HA (blue), FLAG (green), or
Myc (purple). An expression cassette drives production of the Tet repressor-DOZI helicase fusion (TetR-DOZI, black), Renilla luciferase (Ren.
Luc.), and blasticidin-S deaminase selectable marker (BSD). The T7 expression cassette drives transcription of CRISPR guide RNAs (gRNA). (B)
Cloning strategy for editing of the PMV locus. Left and right homologous regions (LHR and RHR) were inserted at FseI and I-SceI respectively,
while the recoded gene sequence was inserted into plasmid cut with AsiSI and BsiWI. The endogenous PMV sequence was disrupted by CRISPR/
Cas9 gene editing. When transcribed, aptamers are bound by TetR-DOZI in the absence of aTc, repressing translation. In the presence of aTc,
TetR-DOZI does not bind the aptamers and translation occurs as normal.

facile cloning, endogenous tagging, robust regulation of
expression and inducible knockout of P. falciparum genes
(Figure 1A, Figure S1). pSN054 has the following features: a
single 5′ aptamer, 10× array of 3′ aptamers, regulatory protein
(TetR-DOZI complex),19 parasitemia-tracking component
(Renilla luciferase), drug selection marker (Blasticidin S
deaminase),22 cassette for generation of sgRNA for CRISPR/
Cas9 genome editing, cloning sites for inserting homologous
sequences for genome repair, modularized aﬃnity tags for
tagging genes of interest at the N- or C-terminus, and loxP
sites for gene excision (Figure 1A).
To utilize pSN054 for genome editing, a gene of interest
must be recodonized to replace the current gene, preventing
aberrant homologous repair from truncating the construct. To
facilitate repair, 400−600 bp of homologous sequence
corresponding to the 5′ and 3′ UTR of a gene, are cloned
into the FseI and I-SceI restriction sites respectively (Figure
S1). This intermediate vector can be used to create gene
knockouts since it does not possess the coding sequence of the
gene of interest. A subsequent Gibson assembly inserts the
coding sequence of the gene. pSN054 contains the 2A skip
peptide23 such that cloning into the AsiSI site produces a
protein with no tag on the N-terminus. If an N- or C-terminal
tag is desired, the relevant restriction site is used for gene
insertion (Figure S1). This donor plasmid can be adapted for
use with the T7-RNAP CRISPR/Cas9 system24 by cloning an
sgRNA into the I-ppoI site. Alternatively, a U6 promotercontaining gRNA plasmid25 can be used and cotransfected
with a ﬁnished pSN054 donor plasmid.
TetR-DOZI Aptamer System for Tagging and Regulation of PMV. To apply pSN054 to PMV, we cloned pieces
of the 5′ UTR and 3′ UTR into FseI and I-SceI, respectively, as
well as a recodonized PMV coding sequence into a plasmid cut

phenotype in RBC culture. The most robust knockdown
described used the glmS ribozyme system, reducing PMV levels
10-fold with no measurable eﬀect on parasite growth or
PEXEL processing.7,16 Here, we sought to apply the recently
described TetR-DOZI aptamer system for stringent and
tunable regulation of PMV.19 This system can deplete a
reporter gene 45 to 70-fold when aptamers are installed in both
the 5′ and 3′ untranslated regions (UTRs) of the target gene.19
However, cloning such a construct in traditional plasmid
systems requires the assembly and maintenance of large
circular plasmids that are prone to deletions and vector
rearrangements during propagation in E. coli.20 To overcome
this technical challenge, we assembled a number of tools for
genetic manipulation onto a previously described linear vector.
Using this new vector system, we achieved substantially greater
depletion of PMV than had been reported. By tuning the
degree of knockdown, we conﬁrmed that PMV is maintained
in substantial excess during RBC infection and must be
suppressed to nearly undetectable levels to aﬀect parasite
growth. Finally, we found that PMV-depleted parasites die
immediately after invasion in a manner distinct from that of
disruptions of other protein export machinery, suggesting PMV
may have additional roles beyond those previously described.

■

RESULTS
Construction of a Linear Vector for Aptamer Knockdowns. To overcome the challenges associated with
maintaining P. falciparum genomic material in circular
plasmids, we utilized the pJAZZ linear vector system20 as a
chassis for DNA assembly. This system has previously been
used to manipulate large [A+T]-rich genomic fragments,
including those derived from the rodent malaria parasite,
P. berghei.20,21 We constructed a plasmid (“pSN054”) to allow
739
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Figure 2. Depletion of PMV demonstrates its essentiality in parasite culture. (A) Tagging was veriﬁed by Southern blot with right homologous
region (RHR) used as probe. Digest schematic shows expected size of bands. The topmost and bottom three bands in the “PMVAPT” lane are
detected in the parent as well and are likely nonspeciﬁc. (B) Protein tagging was veriﬁed by Western blot using an anti-FLAG antibody as well as an
antibody to a cytosolic sugar phosphatase HAD1 as loading control. (C) Expression levels were compared to the parent strain by Western blot
using anti-PMV and anti-HAD1 antibodies. An average ratio of PMV to HAD1 signal from two experiments is shown. (D) Knockdown of PMV
was initiated by washing aTc from ring-stage cultures and adding either 500 nM aTc (+aTc) or an equal volume of DMSO (−aTc). After 72 h,
knockdown was assessed by Western blot, probing with anti-PMV and anti-HAD1. Uncut gels used to generate panels (C) and (D) are shown in
Figure S2. (E) Two separate transfected PMV-regulatable lines (“#1” and “#2”) were split +/− aTc as above and growth monitored daily by ﬂow
cytometry. The experiment was done twice in technical triplicate. A representative experiment is shown, with data points representing mean and
error bars standard deviation.

nM aTc were arrested by 96 h, while parasites maintained in 2
nM aTc survived an additional cycle before arresting at 120 h
(Figure 3A). Given this, we sought to quantify the PMV
depletion necessary to aﬀect parasite growth. We synchronized
parasites and washed out aTc from cultures containing
predominantly young ring-stage parasites, then harvested
samples for Western blot at 72 h following washout to
compare the PMV levels in parasites that would go on to
survive another cycle (2 nM aTc) to those that would arrest in
the next 24 h (1 nM aTc). Over three independent
experiments, we estimate that approximately 8% of wildtype
PMV (2 nM aTc) supports another cycle of growth, while 3%
(1 nM aTc) was insuﬃcient and led to death upon reinvasion
(Figure 3B,C). Since these parasites presumably divide their
PMV, diluting it among their daughter cells before the next
cycle begins, our data suggest that PMV is maintained in
enormous functional excess in parasite culture, with perhaps
less than 1% of wildtype PMV likely suﬃcient to support
growth in parasite culture.
PMV-Depleted Parasites Arrest Early in their Life
Cycle. Given the canonical role of PMV in protein export, we
expected PMV depletion to phenocopy disruption of other
critical export machinery such as components of the
Plasmodium translocon for exported proteins (PTEX) which
mediates translocation of eﬀectors across the PV membrane.3,28,29 PTEX components Hsp101, PTEX150, and
EXP2 are all essential in parasite culture, and depletion of
any of these caused parasite arrest during the early trophozoite
stage.30−32 Therefore, we were surprised to ﬁnd that PMV

with AsiSI and BsiWI (Figure 1B). This plasmid enabled us to
replace the endogenous PMV gene with a FLAG-tagged
recodonized PMV ﬂanked by aptamers. The construct was
cotransfected into the P. falciparum strain NF54attB26 (referred
to as “NF54” throughout) along with a separate gRNAcontaining plasmid pAIO,25 and parasites selected and cloned.
Incorporation of the construct into the genome was veriﬁed by
Southern blot (Figure 2A). Expression of a FLAG-tagged
protein of the expected size was veriﬁed by Western blot
(Figure 2B). Similarly, a Western blot with anti-PMV
antibody veriﬁed that modiﬁcation of this locus did not
substantially change PMV expression levels of the edited line
relative to the parent (Figure 2C).
PMV Is Maintained in Substantial Excess during
Infection. We then utilized the TetR-DOZI aptamer system
to post-transcriptionally deplete PMV. Knockdown was
initiated by washing out anhydrotetracycline (aTc) from
young ring-stage parasites in RBC culture. In the absence of
aTc, PMV levels were depleted about 50-fold (Figure 2D) and
parasite growth was arrested after 96 h (Figure 2E). This
conﬁrms previous reports that PMV is essential for intraerythrocytic growth6,16,27 and showcases the ability of the
TetR-DOZI aptamer system to drive more substantial
depletion of proteins than previously possible.
We next utilized the tunability of the TetR system to
determine the amount of PMV required for parasite survival.
To this end, we titrated aTc levels and followed parasite
growth by ﬂow cytometry. Parasites maintained in 3 nM aTc
or above grew normally. Parasites maintained in DMSO or 1
740
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Figure 3. PMV is maintained in substantial excess. (A) Knockdown of PMV was initiated by washing aTc from ring-stage cultures, and parasites
maintained in 500, 20, 3, 2, 1, or 0 nM (DMSO) aTc. Growth was monitored daily by ﬂow cytometry. Three experiments were performed with
each sample done in technical triplicate. A representative experiment is shown with points representing mean and error bars the standard deviation.
(B) Samples were prepared as in (A) but harvested at 72 h for Western blot. Three experiments were performed. A representative blot is shown.
Uncut gels are shown in Figure S3. (C) Quantiﬁcation of the three Western blots. Blue dots represent mean PMV signal relative to the 500 nM
signal, as quantiﬁed on a diluted standard curve for each experiment (see Materials and Methods); bar height represents the mean of the three
experiments; error bars represent the standard error of the mean.

that ring-stage parasites treated with WEHI-842 arrested as
early trophozoites as previously described (Figure 5A).
However, parasites treated with WEHI-842 beginning in
schizogony arrested immediately after invasion, as was seen
in our genetic PMV depletion line (Figure 5B). Taken
together, our data suggest that parasites are sensitive to PMV
inhibition at two points during asexual growth in RBCs. The
ﬁrst is immediately after invasion. The second is in early
trophozoites and is phenocopied by PTEX disruptions.

depletion caused growth arrest very early in the intraerythrocytic development cycle, arresting as “dots” shortly
after invasion (Figure 4A,B). Arrested parasites were further
investigated by transmission electron microscopy and were
found to have gross structural abnormalities (Figure 4C).
PMV-depleted parasites generally showed more electron
density throughout the parasite cytosol, failure to expand
much beyond the size of merozoites, and large unidentiﬁed
vacuolar structures within the parasite. In contrast, when
parasites were ﬁxed as schizonts from the preceding cycle,
there was no obvious morphological defect (Figure 4D). This
suggests that PMV plays some critical role(s) in successfully
initiating the intraerythrocytic development cycle, distinct from
its canonical protein export role.
To assess whether PEXEL processing was defective at the
time of parasite death, we puriﬁed PMV-depleted schizonts
and allowed them to invade fresh RBCs for 4 h, then probed
the status of the early exported protein RESA by Western blot
and immunoﬂuorescence. PMV depletion led to an accumulation of unprocessed RESA as well as a corresponding defect
in RESA export to the surface of the infected RBC (Figure S4).
PMV Inhibitors Kill Parasites at Multiple Points in the
Intraerythrocytic Development Cycle. Previous work
indicated that PMV inhibitors were lethal at the ringtrophozoite transition, consistent with depletion of PTEX
components.17 Since this diﬀers from our ﬁnding that PMV
depletion arrests parasite growth early after invasion, we sought
to recapitulate the previously described early trophozoite death
as well as our early postinvasion death with the peptidomimetic PMV inhibitor WEHI-842.17,18 We treated synchronized
ring-stage parasites or schizonts with 5 μM WEHI-842 for an
8-h window, then monitored parasites by thin smear. We found

■

DISCUSSION
We report the ﬁrst regulatable knockdown that lowers PMV
levels enough to reveal a lethal phenotype. This work
overcomes the technical limitations of past knockdown systems
by utilizing the TetR system with aptamers on both the 5′ and
3′ end of the gene of interest. This manipulation was facilitated
by the plasmid described here, pSN054, which enables a suite
of previously described genetic tools to be utilized with relative
ease for gene editing to achieve protein tagging, regulation of
gene expression, parasite growth monitoring and inducible
knockout as required.
An unexpected result is that PMV depletion does not
phenocopy the disruption of PTEX components.30−32 The fact
that the early death phenotype described here is not seen in
disruption of other export machinery suggests that PMV has a
role independent of protein export that is essential for parasite
survival in RBCs. A reasonable hypothesis is that this role
could be the cleavage of a critical substrate early in the life
cycle to allow it to perform an essential activity. In this case,
the substrate would likely be acting within the parasite or
parasitophorous vacuole, since disruption of Hsp101 function
with a destabilization domain blocked nearly all exported
741
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Figure 4. PMV-depleted parasites arrest early in their life cycle. (A) aTc was washed from ring-stage parasites, which were then maintained in 500
nM aTc (+aTc) or an equal volume of DMSO (−aTc). Parasite growth was monitored by Hemacolor-stained thin smear. Experiment was
performed three times (B) Phenotype quantiﬁcation for 0- to 4-h rings (N = 208 parasites +aTc; 105 parasites −aTc). (C) Parasites maintained as
above. At 96 h, parasites were ﬁxed, and early ring-stage parasites visualized by transmission electron microscopy. (D) Parasites were maintained as
in (C) except schizonts were harvested at 90 h following aTc washout. Scale bars represent 1 μm.

Figure 5. PMV inhibition arrests parasite growth at two distinct points in the life cycle. Parasites were synchronized to within 3 h, then treated with
5 μM WEHI-842 for an 8-h window beginning either in (A) ring-stage (12 to 15 h after invasion) or (B) early schizont (41 to 44 h after invasion).
At the beginning and end of each window, parasites were monitored by Hemacolor-stained thin smear. The experiment was performed twice;
representative images from one experiment are shown.

their N-termini.34,35 Similarly, in Plasmodium, the dense
granule protein RESA is cleaved at a “relaxed” PEXEL
sequence of RxLxxE10 by PMV (Figure S4). It is then rapidly
secreted into the PV during parasite invasion.10 While RESA is
dispensable for intraerythrocytic growth,36 other PMV
substrates may follow a similar traﬃcking route and may be

eﬀectors within the vacuole but only arrested growth in early
trophozoites.30 One possible source of essential PMV
substrates is parasite secretory organelles called dense granules
that are involved in establishing the PV.33 In the Apicomplexan
parasite Toxoplasma gondii, the PMV ortholog Asp5 primarily
cleaves dense granule eﬀectors at a PEXEL-like sequence near
742
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UTR) was ampliﬁed from NF54 genomic DNA using primers
TTGGTTTTCAAACTTCATTGACTGTGCCGACATTAATTTGTGTAACATATAAATATGTAG and AAGTTATGAGCTCCGGCAAATGACAAGGGCCGGCCCTTTCCTTAAAAAATAATTATTGAT, and cloned into the FseI
site. PMV was codon-optimized for expression in Saccharomyces cerevisiae and synthesized as gene blocks by Integrated
DNA Technologies (Coralville, IA) then cloned into the vector
at the AsiSI and BsiWI sites. The plasmid was grown in
BigEasy Electrocompetent Cells (Lucigen) with 12.5 μg/mL
chloramphenicol and 0.01% (w/v) arabinose.
CRISPR/Cas9 editing was performed as previously
described.25 Guide RNA sequences were inserted into the
pAIO vector by annealing oligonucleotides of the sequences
ATTAAGTATATAATATTTGTAATGGTTGTAAAGATTGGTTTTAGAGCTAGA and TCTAGCTCTAAAACCAATCTTTACAACCATTACAAATATTATATACTTAAT
and inserting them into BtgZI-cut pAIO by In-Fusion HD
Cloning (Clontech). pAIO was maintained in XL10 Gold cells
(Agilent Technologies). Bold sequences represent the gRNA
site.
For each transfection, 100 μg of donor vector and 50 μg of
pAIO were transfected into early ring-stage parasites in 2 mm
gap electroporation cuvettes (Fisher) using a BioRad Gene
Pulser II. Transfectants were maintained in 0.5 μM
anhydrotetracycline (aTc; Cayman Chemical) and were
selected beginning 24 h post-transfection with Blasticidin S
(2.5 μg/mL; Fisher). Parasites were obtained from several
independent transfections and clones obtained by limiting
dilution.
Validation of PMVAPT Line. Proper integration of our
construct was veriﬁed by Southern Blot as in ref 24. For a
probe, the right homologous region was ampliﬁed from NF54
genomic DNA using primers described above.
To verify tagging of protein, schizonts of NF54 and PMVAPT
were ﬁrst synchronized by purifying on magnetic columns
(Miltenyi Biotech) then allowed to invade fresh uninfected
RBCs for 3 h before remaining schizonts were cleared with 5%
sorbitol. Parasites were then allowed to progress for 40 h, then
RBCs lysed with cold PBS + 0.035% saponin. Samples were
centrifuged to pellet parasites and remove excess hemoglobin,
then parasites lysed in RIPA (50 mM Tris, pH 7.4; 150 mM
NaCl; 0.1% SDS; 1% Triton X-100; 0.5% DOC) plus HALTProtease Inhibitor Cocktail, EDTA-free (Thermo Fisher).
Lysates were centrifuged at high speed to pellet and remove
hemozoin. Cleared lysates were then diluted in SDS sample
buﬀer (10% SDS, 0.5 M DTT, 2.5 mg/mL bromophenol blue,
30% 1 M Tris pH 6.8, 50% glycerol) and boiled for 5 min.
Lysates were separated by SDS-PAGE, then transferred to 0.45
μm nitrocellulose membrane (BioRad). Membranes were
blocked in PBS + 3% bovine serum albumin, then probed
with primary antibodies mouse anti-PMV 1:2541 or anti-FLAG
1:500 (M2, Sigma), and rabbit anti-HAD1 1:1000.42
Membranes were washed in PBS + 0.1% Tween 20, then
incubated with secondary antibodies goat antimouse IRDye
800CW 1:10,000 (Licor) and donkey antirabbit IRDye 680RD
1:10 000 (Licor). Membranes were then washed in PBS +
0.1% Tween 20 and imaged on a Licor Odyssey platform.
Assessment of Knockdown. To assess the eﬀect of PMV
knockdown on parasite growth, aTc was removed from
cultures by washing 3 times for 5 min each in media without
aTc, then either 500 nM aTc (“+aTc”) or DMSO (“−aTc”)
was added and parasites split into 1 mL triplicate cultures for

required early in the intraerythrocytic development cycle.
Alternatively, early death could be a nonspeciﬁc result of PMV
deﬁciency, such as a buildup of uncleaved PEXEL proteins in
the ER. Consistent with this, treatment with the canonical ERstress inducer DTT arrested growth in P. falciparum with
similar morphology by Giemsa stain to that caused by PMV
depletion described here.37
One encouraging note for the development of PMV
inhibitors as antimalarials is our ﬁnding that PMV inhibition
can lead to parasite death at two distinct points within
intraerythrocytic development. Knockdown of PTEX components seems to cause growth arrest only at the early
trophozoite stage in blood-stage parasites.30−32 Due to this,
drugs inhibiting the function of PTEX components may take
up to a full intraerythrocytic cycle (48 h) to reach the point in
the cycle where growth arrest occurs. In contrast, PMV
inhibitors may arrest growth more quickly by acting upon
intraerythrocytic parasites at more than one point in the life
cycle. Recent work has also shown that PMV inhibitors can
block development of early stage gametocytes, and have a
transmission-blocking eﬀect.38 Together, these ﬁndings bolster
the case that PMV inhibitors can have properties in line with
the target antimalarial proﬁles put forward by the Medicines
for Malaria Venture.39 However, these beneﬁcial characteristics
are counterbalanced by our ﬁnding that PMV must be
suppressed to barely detectable levels to aﬀect parasite growth.
Peptidomimetic inhibitors of PMV that have been developed
are generally greater than 100-fold less potent in culture than
on isolated enzyme.16,17,40 It has been presumed that potency
against parasites is limited by cellular permeability. Our
functional genetics data would suggest that an additional,
and possibly major, component of the potency drop-oﬀ is the
need to inhibit nearly all the cellular enzyme to kill parasites. It
is possible that a potent compound with good biochemical and
pharmacokinetic properties could overcome this barrier to
suﬃciently inhibit PMV during human infection to achieve
high antimalarial eﬃcacy.
Taken together, our study provides further data on the
proposed antimalarial drug target plasmepsin V. Future work is
needed to determine if PMV is maintained at excessive levels in
vivo as it is in vitro, and to elucidate the cause of growth arrest
after invasion in PMV-depleted parasites.

■

MATERIALS AND METHODS
Parasite Lines and Culture. P. falciparum strain NF54attB
(referred to as NF54 throughout) was used as a parent strain
for transfections.26 Asexual parasites were cultured in RPMI
1640 (Gibco) supplemented with 0.25% (w/v) Albumax, 15
mg/L hypoxanthine, 110 mg/L sodium pyruvate, 1.19 g/L
HEPES, 2.52g/L sodium bicarbonate, 2 g/L glucose, and 10
mg/L gentamycin. Deidentiﬁed RBCs were obtained from the
Barnes-Jewish Hospital blood bank (St. Louis, MO), St. Louis
Children’s Hospital blood bank (St. Louis, MO), and from
American Red Cross Blood Services (St. Louis, MO).
Generation of Knockdown Line. The construct for
aptamer regulation of PMV was constructed using pSN054,
described above. The right homologous region (3′ UTR) was
ampliﬁed from NF54 genomic DNA using primers AGTGGTGTACGGTACAAACCCGGAATTCGAGCTCGGGGAATCAACATAGAAACGTTAAAG and GATTGGGTATTAGACCTAGGGATAACAGGGTAATGTACTAGGTCATTTTCTTTATTTTAC, and cloned into the I-SceI site using
Gibson Assembly (NEB). The left homologous region (5′
743
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each condition. Parasite growth was monitored daily by ﬂow
cytometry (BD FACSCanto) using acridine orange (1.5 μg/
mL in PBS). Parasites were subcultured every 48 h to prevent
overgrowth. “Cumulative parasitemia” was back-calculated
based on the subculture schedule. Flow cytometry data is
plotted with each point representing the mean of three
technical replicates with error bars showing the standard
deviation. Experiments were done three times unless otherwise
noted.
For titrations of aTc, parasite cultures were washed as above
to remove aTc, then cultures were maintained in media
containing the shown concentrations of aTc or DMSO (aTc
stocks were diluted to ensure each culture received equal
volumes of the solvent DMSO in order to attain the desired
ﬁnal aTc concentration). To determine the eﬀect of aTc
concentration on PMV levels, cultures were prepared as above,
and samples taken for Western blot 72 h after aTc was
removed. Sample preparation and Western blotting was done
as above (see the Validation of PMVAPT Line section). To
quantitate PMV titration blots, the 500 nM sample was diluted
out by factors of two to draw a standard curve correlating a
PMV signal to a relative amount of the 500 nM sample (see
Figure S3). Blots were quantitated using Licor Image Studio.
The experiment was performed three times, and the mean for
those three experiments is plotted with error bars representing
the standard error of the mean.
WEHI-842 Treatment. NF54attB parasites were synchronized to within 3 h as above (see the Validation of PMVAPT Line
section above, paragraph 2). Then either 5 μM WEHI-842, or
an equal volume of DMSO was added to late rings (15 h after
invasion initiated; parasites 12−15 h old), or late trophozoites
(44 h after invasion initiated; parasites 41−44 h old). Parasites
were incubated with drug or DMSO for 8 h, then assessed by
thin smear. The experiment was performed twice, with similar
results in each. Representative images from one experiment are
shown.
Microscopy. Parasites monitored by thin smear were dyed
using Harleco Hemacolor stains (MilliporeSigma). Images
were taken using a Zeiss Axio Observer.D1 at the Washington
University Molecular Microbiology Imaging Facility. For
transmission electron microscopy, infected RBCs were ﬁxed
in 2% paraformaldehyde/2.5% glutaraldehyde (Polysciences
Inc., Warrington, PA) in 100 mM sodium cacodylate buﬀer,
pH 7.2 for 1 h at room temperature. Samples were washed in
sodium cacodylate buﬀer at room temperature and postﬁxed in
1% osmium tetroxide (Polysciences Inc.) for 1 h. Samples were
rinsed extensively in deionized water prior to en bloc staining
with 1% aqueous uranyl acetate (Ted Pella Inc., Redding, CA)
for 1 h. Following several rinses in deionized water, samples
were dehydrated in a graded series of ethanol and embedded in
Eponate 12 resin (Ted Pella Inc.). Sections of 95 nm were cut
with a Leica Ultracut UCT ultramicrotome (Leica Microsystems Inc., Bannockburn, IL), stained with uranyl acetate
and lead citrate, and viewed on a JEOL 1200 EX transmission
electron microscope (JEOL USA Inc., Peabody, MA) equipped
with an AMT 8-megapixel digital camera and AMT Image
Capture Engine V602 software (Advanced Microscopy
Techniques, Woburn, MA).
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Figure S1: Cloning schematic for using pSN054; Figure
S2: Uncut gels used to generate Figure 2; Figure S3:
Uncut gels used to generate Figure 3B,C; Figure S4:
PMV is required for processing and export of RESA
(PDF)
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